News
Last Chance to Register: Ethics Webinar: Navigating the Evolving Regulatory Landscape - 21 October at 11.30 UK
This is the second of two EPHMRA Ethics webinars to equip you with the knowledge and tools to navigate the complex regulatory landscape and opportunities of healthcare market research.
This event delves into the impact of downstream AI regulations and the power of using AI on the healthcare insights industry.
Would you like to have the opportunity to influence the future of EPHMRA?
As a member, you will have chance to share your views and expertise by playing an active role on Committees that liaise with the Board.
Along with helping members achieve professional excellence, our Committees support their needs by sharing best practice, and keeping them up to date with industry developments.
Send in your Synopsis for the 2025 Conference, 24 - 26 June, London
The Call for Papers is Launched! Submission deadline is 23 September 2024
The 2024 Conference was a great success and we are now excited to plan our June 2025 event. Can you add your voice by submitting an idea for a paper?
Basel meeting on 19 September 2024
‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis
The 2024 Adverse Event Reporting Guidelines are now available.
The EPHMRA AER Guidelines have been written for Marketing Authorisation Holders (MAH/CH) or Certificate Holders and market research agencies (MRA) on the collection and reporting of an Adverse Event (AE) of medicinal products and medical devices.
Our final paper to be announced for the 2024 EPHMRA Basel Chapter meeting is entitled: Ethnic Disparities in Multiple Myeloma Treatment: A Holistic Analysis from Real-World Data.
As an Association we are happy to receive Code enquiries from EPHMRA Member companies.
These enquiries need to reference the section of the Code you have a question about, but we are unable to answer any questions of a commercial nature.
Our ethics consultants assess and review each question received and there is no charge for this service as it is a Member benefit.
The 2024 Basel Chapter meeting will be taking place 19 September at the Novartis Campus.
There we will be joined by Jeremy Hollow, Listen and Learn Research, to present their paper: Beyond Side Effects: Using social media to give a patient-centric understanding of medication adhere
Members can register for just 200
Our next paper at the 2024 Basel Chapter meeting, is called ‘Evaluating Consumer Preferences and Attitudes Through AI-Driven Patient Interviews’.
The speaker for this paper is – Mattia Marco Caruson, Mama Health Technologies
At the EPHMRA Basel Chapter meeting 2024, our paper from IQVIA will be entitled: The Inevitability of Bias (The Challenge Of Achieving Diversity).
This paper will be presented by speakers: Hafsah Rana and Sandra Flierl